Literature DB >> 7934579

[Surgical strategy in persistence and recurrence in surgery of primary hyperparathyroidism].

C Dotzenrath1, P E Goretzki, H D Röher.   

Abstract

Persisting hypercalcemia after surgery for primary hyperparathyroidism is a challenge for the surgeon: once non-parathyroid causes for the hypercalcemia have been excluded the only remaining possible causes are ineffective surgery and a failed surgery. Between 1986 and 1994, 414 patients with primary hyperparathyroidism were operated upon, 32 of whom presented with persisting hypercalcemia; 24 of these patients had their first operation in another hospital. The cause for persisting hypercalcemia was a single adenoma in 27 patients (84%), double adenoma in 2 patients and primary hyperplasia in 2 patients. In 1 patient an unsuccessful revision operation was performed. In 17 patients the parathyroid glands had an atypical position. There were 11 patients who presented with recurrent hyperplasia. The reasons for recurrence were double adenoma in 2 patients and hyperplasia in 8 cases (73%). In 1 patient no pathologic gland was found. Although preoperative localization studies were positive in only 32%, the overall surgical success rate fortunately amounted to a satisfactory 95%.

Entities:  

Mesh:

Year:  1994        PMID: 7934579     DOI: 10.1007/bf00186361

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  34 in total

1.  Initial failure of surgical exploration in patients with primary hyperparathyroidism.

Authors:  L J Auguste; J N Attie; D Schnaap
Journal:  Am J Surg       Date:  1990-10       Impact factor: 2.565

2.  Management of patients with persistent or recurrent primary hyperparathyroidism.

Authors:  S E Carty; J A Norton
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

Review 3.  [First cervicotomy for primary hyperparathyroidism. Argument against preoperative imaging].

Authors:  C Proye
Journal:  Ann Chir       Date:  1990

Review 4.  [Mediastinal exploration by sternotomy in surgery of hyperparathyroidism. 36 cases].

Authors:  C I Dubost; P Y Bouteloup
Journal:  J Chir (Paris)       Date:  1988-11

5.  Localizing studies in patients with persistent or recurrent hyperparathyroidism.

Authors:  K E Levin; G A Gooding; M Okerlund; C B Higgins; D Norman; T H Newton; Q Y Duh; C D Arnaud; A E Siperstein; Q H Zeng
Journal:  Surgery       Date:  1987-12       Impact factor: 3.982

6.  Reoperative parathyroid surgery.

Authors:  P J Billings; E J Milroy
Journal:  Br J Surg       Date:  1983-09       Impact factor: 6.939

7.  Persistent and recurrent hyperparathyroidism.

Authors:  J J Roslyn; D G Mulder; H E Gordon
Journal:  Am J Surg       Date:  1981-07       Impact factor: 2.565

8.  Reoperative parathyroid surgery for persistent hyperparathyroidism.

Authors:  M F Brennan; J L Doppman; S J Marx; A M Spiegel; E M Brown; G D Aurbach
Journal:  Surgery       Date:  1978-06       Impact factor: 3.982

9.  Diagnosis of recurrent hyperparathyroidism: comparison of MR imaging and other imaging techniques.

Authors:  W Auffermann; G A Gooding; M D Okerlund; O H Clark; S Thurnher; K E Levin; C B Higgins
Journal:  AJR Am J Roentgenol       Date:  1988-05       Impact factor: 3.959

10.  Metastatic parathyroid carcinoma: dilemmas in management.

Authors:  K Sandelin; N W Thompson; L Bondeson
Journal:  Surgery       Date:  1991-12       Impact factor: 3.982

View more
  3 in total

1.  European endocrine surgery in the 150-year history of Langenbeck's Archives of Surgery.

Authors:  Henning Dralle; A Machens
Journal:  Langenbecks Arch Surg       Date:  2010-03-09       Impact factor: 3.445

2.  [Results of surgical therapy in renal hyperparathyroidism. Follow-up of 143 patients].

Authors:  C Dotzenrath; P E Goretzki; H D Roher
Journal:  Langenbecks Arch Chir       Date:  1996

3.  Impact of "Tailored" Parathyroidectomy for Treatment of Primary Hyperparathyroidism in Patients with Multiple Endocrine Neoplasia Type 1.

Authors:  Kiyomi Horiuchi; Momoko Sakurai; Kento Haniu; Erin Nagai; Hiroki Tokumitsu; Yusaku Yoshida; Yoko Omi; Akiko Sakamoto; Takahiro Okamoto
Journal:  World J Surg       Date:  2018-06       Impact factor: 3.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.